MOESM1 of Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies — Cristina Razquín | RDL Network
MOESM1 of Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies
Cristina Razquín, Miguel Ruiz‐Canela, Clary B. Clish, Jun Li, Estefanía Toledo, Courtney Dennis, Liming Liang, Albert Salas‐Huetos, Kerry A. Pierce, Marta Guasch‐Ferré, Dolores Corella, Emilio Ros, Ramón Estruch, Enrique Gómez‐Gracia, Montserrat Fitó, José Lapetra, Dora Romaguera, Ángel M. Alonso‐Gómez, Lluís Serra‐Majem, Jordi Salas‐Salvadó, Frank B Hu, Miguel Ángel Martínez‐González
Edward Yu, Christopher Papandreou, Miguel Ruiz‐Canela, Marta Guasch‐Ferré, Clary B. Clish, Courtney Dennis, Liming Liang, Dolores Corella, Montserrat Fitó, Cristina Razquín, José Lapetra, Ramón Estruch, Emilio Ros, Montserrat Cofán, Fernando Arós, Estefanía Toledo, Lluís Serra‐Majem, José V. Sorlí, Frank B Hu, Miguel Ángel Martínez‐González, Jordi Salas‐Salvadó
Marta Guasch‐Ferré, Frank B Hu, Miguel Ruiz‐Canela, Mònica Bulló, Estefanía Toledo, Dong D. Wang, Dolores Corella, Enrique Gómez‐Gracia, Miquel Fiol, Ramón Estruch, José Lapetra, Montserrat Fitó, Fernando Arós, Lluís Serra‐Majem, Emilio Ros, Courtney Dennis, Liming Liang, Clary B. Clish, Miguel Ángel Martínez‐González, Jordi Salas‐Salvadó
Discussion(0)
No comments yet. Be the first to comment.